SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.803
AS - Asia 9.060
EU - Europa 5.292
SA - Sud America 1.566
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 222
OC - Oceania 12
AN - Antartide 1
Totale 33.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.325
SG - Singapore 3.341
CN - Cina 2.197
IT - Italia 1.375
BR - Brasile 1.221
VN - Vietnam 1.096
DE - Germania 816
HK - Hong Kong 706
UA - Ucraina 547
GB - Regno Unito 478
PL - Polonia 437
TR - Turchia 437
FI - Finlandia 380
FR - Francia 315
BD - Bangladesh 281
CA - Canada 279
SE - Svezia 278
JP - Giappone 231
RU - Federazione Russa 206
IN - India 202
ID - Indonesia 151
AR - Argentina 120
MX - Messico 117
NL - Olanda 103
ZA - Sudafrica 88
IQ - Iraq 62
ES - Italia 58
CO - Colombia 53
BE - Belgio 50
EC - Ecuador 49
AT - Austria 48
PK - Pakistan 45
LT - Lituania 41
UZ - Uzbekistan 41
VE - Venezuela 38
MY - Malesia 36
CZ - Repubblica Ceca 31
SA - Arabia Saudita 30
CL - Cile 27
MA - Marocco 27
AE - Emirati Arabi Uniti 26
KE - Kenya 26
TN - Tunisia 24
CH - Svizzera 23
PH - Filippine 23
PY - Paraguay 22
JM - Giamaica 21
KR - Corea 17
CR - Costa Rica 16
EG - Egitto 16
JO - Giordania 16
IE - Irlanda 15
IL - Israele 15
NP - Nepal 14
BO - Bolivia 13
AU - Australia 12
DZ - Algeria 12
HN - Honduras 12
PE - Perù 11
PT - Portogallo 11
ET - Etiopia 10
TW - Taiwan 10
UY - Uruguay 10
BG - Bulgaria 9
EU - Europa 8
IR - Iran 8
KZ - Kazakistan 8
TH - Thailandia 8
HU - Ungheria 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
RS - Serbia 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
RO - Romania 6
DO - Repubblica Dominicana 5
GR - Grecia 5
PA - Panama 5
SY - Repubblica araba siriana 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CG - Congo 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
CY - Cipro 3
GE - Georgia 3
KH - Cambogia 3
KW - Kuwait 3
MK - Macedonia 3
NI - Nicaragua 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
Totale 32.925
Salva come PNG Salva come JPEG
Città #
Singapore 2.106
Ashburn 2.095
Fairfield 1.189
Woodbridge 1.156
San Jose 1.128
Chandler 795
Beijing 777
Houston 742
Santa Clara 719
Ann Arbor 709
Hong Kong 687
Jacksonville 621
Seattle 504
Wilmington 473
Cambridge 421
Warsaw 419
Los Angeles 379
Ferrara 377
Council Bluffs 374
Ho Chi Minh City 345
New York 312
Dallas 298
Hanoi 267
Munich 248
Izmir 236
Tokyo 216
Nanjing 169
Helsinki 167
Princeton 163
Lauterbourg 162
Milan 156
Shanghai 137
São Paulo 124
Boardman 119
Jakarta 117
Orem 111
San Diego 110
Buffalo 101
Toronto 95
Turku 90
London 83
Chicago 77
Montreal 71
The Dalles 70
Chennai 69
Bologna 68
Frankfurt am Main 66
Mexico City 65
Denver 63
Tianjin 62
Da Nang 58
Bremen 57
Brooklyn 55
Nanchang 53
Johannesburg 51
Phoenix 50
San Francisco 49
Shenyang 49
Atlanta 47
Brussels 47
Dearborn 47
Stockholm 45
Hefei 43
Manchester 42
Haiphong 41
Rome 41
Boston 40
Moscow 37
Hebei 36
Nuremberg 36
Tashkent 36
Columbus 35
Jiaxing 35
Falls Church 34
Falkenstein 33
Poplar 33
Amsterdam 32
Changsha 31
Rio de Janeiro 31
Belo Horizonte 28
Washington 27
Ankara 25
Auburn Hills 24
Norwalk 24
Zhengzhou 24
Brno 23
Curitiba 23
Dong Ket 22
Baghdad 21
Biên Hòa 21
Des Moines 21
Guangzhou 21
Mountain View 21
Porto Alegre 21
Kuala Lumpur 19
Zurich 19
Augusta 18
Brasília 18
Florence 18
Hải Dương 18
Totale 21.788
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 424
Pharmacology of Adenosine Receptors: The State of the Art 418
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 315
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 308
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
The A3 adenosine receptor: history and perspectives 293
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 292
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 291
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 290
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 283
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 280
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 279
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 278
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 274
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 269
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 266
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 266
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 266
Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia 265
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 264
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 258
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 257
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 257
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 249
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 245
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 245
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 244
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 241
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 240
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 234
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 227
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 227
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 226
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 222
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 222
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 221
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 220
Pathological overproduction: the bad side of adenosine 219
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 217
Targeting A3 and A2A adenosine receptors in the fight against cancer 217
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 216
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 216
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 215
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 212
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 211
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 210
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 208
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 204
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 204
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 203
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 201
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 201
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 200
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 200
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 199
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 199
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 196
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 196
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 195
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 194
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 188
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 187
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 187
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 187
Development of novel pyridazinone-based adenosine receptor ligands 185
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 183
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 182
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 182
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. 178
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 177
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 177
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 176
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 175
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 173
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 172
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E2 and cytokine production in human osteoarthritic synovial fibroblasts 172
A2A adenosine receptors and chronic caffeine intake in human neutrophils 171
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 170
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition (dagger). 170
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 169
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases 169
The role of adenosine receptors in rheumatoid arthritis. 168
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 168
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 168
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter 165
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 164
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 164
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 163
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 163
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 163
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 163
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 162
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 162
Adenosine and inflammation: Here, there and everywhere 162
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 161
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 161
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 158
Upregulation of Cortical A2Aadenosine receptors is reflected in platelets of patients with Alzheimer's Disease 158
Totale 21.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.539
Totale 148.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.451 0 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20255.044 109 151 374 288 469 510 241 284 803 515 695 605
2025/202613.732 1.329 544 1.110 1.570 2.017 926 1.558 773 1.273 1.535 690 407
2026/20271.070 472 598 0 0 0 0 0 0 0 0 0 0
Totale 33.391